Glaxo Diabetes Drug Performs Well In Study
June 7, 2009 by admin · Leave a Comment

GlaxoSmithKline are reporting positive results for their new experimental drug to treat people diagnosed with diabetes.
Their drug, called Albiglutide was proven to be very good in clinical trials at lowering the blood sugar of people with diabetes to an exceptable level. Read more
Amylin Diabetes Drug Outperforms Leading Rivals
June 7, 2009 by admin · Leave a Comment

It is being reported that a new diabetes drug made by Amylin has outperformed Actos and Januvia in a clinical trial.
Actos and Januvia are major players in the drug market when it comes to diabetes, thus this study finding will surely be a major blow to their sales. Read more
Study Proves Avandia Does Not Cause Heart Attacks
June 6, 2009 by admin · Leave a Comment

Results of a new study have found no risk of heart health issues in patients given the drug avandia to help treat their diabetes.
Avandia is manufactured by GlaxoSmithKline and is prescribed to people suffering with diabetes. Read more
Merck’s Rolofylline Fails To Meet Study Goals
June 5, 2009 by admin · Leave a Comment

It is being reported that Merck will not be applying to the FDA for approval of their heart failure drug because it did not meet study goals.
Heart failure occurs when the heart becomes weak to the point where it is unable to sufficiently pump blood throughout the entire body. Read more
Johnson And Johnson Developing Drug For Resistant Tuberculosis
June 4, 2009 by admin · Leave a Comment

There is a new experimental drug being developed by Johnson and Johnson that has shown promise at treating drug resistant tuberculosis.
The drug is called TMC207, and is in early stages of development but so far, the results have been very positive. Read more
FDA Wants More Clinical Data On Cinryze Drug
June 4, 2009 by admin · Leave a Comment

The Food and Drug Administration (FDA) have sent a complete response letter to ViroPharma concerning their experimental drug, Cinryze.
The drug was developed to treat a rare genetic medical condition, but according to the FDA the company have not proven that it can be used as an effective treatment. Read more
(Update) Pfizer Develops Drug To Fight Cancer In Dogs
June 4, 2009 by admin · Leave a Comment

The Food and Drug Administration (FDA) have approved Palladia, the world’s first drug specifically developed to treat cancer in dogs.
The drug is manufactured by Pfizer Inc, and according to the company will be ready for distribution sometime next year. Read more
Drug Makers Join Forces To Fight Bad Cholesterol
June 4, 2009 by admin · Leave a Comment

It is being reported that AstraZeneca in combination with Abbott have filed an approval application to the Food and Drug Administration for their cholesterol drug.
Their drug goes by the name of Certriad, and is a combination pill containing both Crestor and TriLipix for the lowering of bad levels of cholesterol. Read more
Consumer Group: FDA Should Stop Review Of Blood Thinner
June 3, 2009 by admin · Leave a Comment

A consumer group is requesting that the Food and Drug Administration (FDA) stop the review of an Eli Blood thinning drug called prasugrel.
According to Public Citizen, the recommended dosage instructions for the drug are far too high, a fact that puts patients who receive it at increased risk of internal bleeding. Read more
(Update) Treating Autistic Children With Antidepressants May Worsen Condition
June 2, 2009 by admin · Leave a Comment

Autistic children treated with the antidepressant drug Celexa were no more likely to have reduced symptoms of their condition say researchers of a new study.
Celexa is commonly prescribed for children with autism as doctors feel it works to reduce bouts of abnormal behavior. Read more





















































